Drug Information

Drug General Information
Drug ID
D0K6MM
Former ID
DNC006171
Drug Name
N-(furan-2-ylmethyl)estradiol-16-carboxamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528033]
Structure
Download
2D MOL

3D MOL
Formula
C24H29NO4
Canonical SMILES
CC12CCC3C(C1CC(C2O)C(=O)NCC4=CC=CO4)CCC5=C3C=CC(=C5)O
InChI
1S/C24H29NO4/c1-24-9-8-18-17-7-5-15(26)11-14(17)4-6-19(18)21(24)12-20(22(24)27)23(28)25-13-16-3-2-10-29-16/h2-3,5,7,10-11,18-22,26-27H,4,6,8-9,12-13H2,1H3,(H,25,28)/t18?,19?,20?,21?,22-,24-/m0/s1
InChIKey
JKEJHEHCKBFOBU-OOBULCBASA-N
PubChem Compound ID
44407336
Target and Pathway
Target(s) Estradiol 17 beta-dehydrogenase 1 Target Info Inhibitor [528033]
BioCyc Pathway Superpathway of steroid hormone biosynthesis
Estradiol biosynthesis I
KEGG Pathway Steroid hormone biosynthesis
Metabolic pathways
Ovarian steroidogenesis
NetPath Pathway FSH Signaling Pathway
PANTHER Pathway Androgen/estrogene/progesterone biosynthesis
PathWhiz Pathway Androgen and Estrogen Metabolism
Reactome The canonical retinoid cycle in rods (twilight vision)
WikiPathways Steroid Biosynthesis
Metabolism of steroid hormones and vitamin D
Prostate Cancer
References
Ref 528033J Med Chem. 2006 Feb 23;49(4):1325-45.Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Ref 528033J Med Chem. 2006 Feb 23;49(4):1325-45.Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.